{
  "zip": "4123",
  "sector": "Healthcare",
  "longBusinessSummary": "Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia Ltd has a collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; ReveraGen to research and co-develop vamorolone, a non-hormonal steroid modulator for the treatment of duchenne muscular dystrophy; and Hoffman-La Roche Inc. to develop and market compounds in the field of cancer immunotherapy. It also has a collaboration with Antares Pharma, Inc. for the development of a self- administered drug device product for Selatogrel; and Neurocrine Biosciences, Inc. to develop and commercialize ACT-709478, which is in Phase 1 clinical trial for the treatment of epilepsy. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland.",
  "city": "Allschwil",
  "phone": "41 58 844 10 10",
  "country": "Switzerland",
  "companyOfficers": [],
  "website": "http://www.idorsia.com",
  "maxAge": 1,
  "address1": "Hegenheimermattweg 91",
  "industry": "Biotechnology",
  "previousClose": 31.37,
  "regularMarketOpen": 31,
  "twoHundredDayAverage": 28.515741,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 31,
  "navPrice": null,
  "averageDailyVolume10Day": 2552,
  "totalAssets": null,
  "regularMarketPreviousClose": 31.37,
  "fiftyDayAverage": 29.357712,
  "trailingAnnualDividendRate": null,
  "open": 31,
  "averageVolume10days": 2552,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.782258,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 30.91,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 410,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 5079656448,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 1022,
  "priceToSalesTrailing12Months": null,
  "dayLow": 30.91,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 410,
  "fiftyTwoWeekHigh": 34.75,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 18.57,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 31,
  "exchange": "PNK",
  "shortName": "IDORSIA LTD",
  "longName": "Idorsia Ltd",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "IDRSF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_418070523",
  "uuid": "7567121c-a1e8-315a-862e-2c66fcc9c342",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 166447008,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 5.978,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.20968,
  "netIncomeToCommon": null,
  "trailingEps": -1.773,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 5.1706257,
  "heldPercentInsiders": 0.29253998,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 125586760,
  "enterpriseValue": 5221684736,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 31,
  "logo_url": "https://logo.clearbit.com/idorsia.com"
}